Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.
Aromatase is a cytochrome P-450 enzyme that catalyzes the conversion of androgens into oestrogens via sequential oxidations at the 19-methyl group. Despite intensive investigation, the mechanism of the third step, conversion of the 19-aldehydes into oestrogens, has remained unsolved. We have previously found that a pre-enolized 19-al derivative undergoes smooth aromatization in non-enzymic model studies, but the role of enolization by the enzyme in transformations of 19-oxoandrogens has not been previously investigated. The compounds 19-oxo[2 beta-2H]testosterone and 19-oxo[2 beta-2H]androstenedione have now been synthesized. Exposure of either of these compounds to microsomal aromatase, in the absence of NADPH, for an extended period led to no significant 2H loss or epimerization at C-2, leaving open the importance of an active-site base. However, in the presence of NADPH there was an unexpected substrate-dependent difference in the stereoselectivity of H loss at C-2 in the enzyme-induced aromatization of 19-oxo[2 beta-2H]-testosterone versus 19-oxo[2 beta-2H]androstenedione. The aromatization results for 17 beta-ol derivative 19-oxo[2 beta-2H]-testosterone correspond to about 1.2:1 2 beta-H/2 alpha-H loss from unlabelled 19-oxotestosterone. In contrast, aromatization results for 19-oxo[2 beta-2H]androstenedione correspond to at least 11:1 2 beta-H/2 alpha-H loss from unlabelled 19-oxoandrostenedione. This substrate-dependent stereoselectivity implies a direct role for an enzyme active-site base in 2-H removal. Furthermore, these results argue against the proposal that 2 beta-hydroxylation is the obligatory third step in aromatase action.
Cole
P A
PA
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Robinson
C H
CH
D000735:Androstenedione / Q000031:analogs & derivatives* / Q000378:metabolism; D001141:Aromatase / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D006801:Humans; D006915:Hydroxytestosterones / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008861:Microsomes / Q000201:enzymology; D009249:NADP / Q000494:pharmacology; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D013237:Stereoisomerism; D013739:Testosterone / Q000031:analogs & derivatives*
D004967:Estrogens; D006915:Hydroxytestosterones; D013739:Testosterone; D000735:Androstenedione; C036445:19-hydroxytestosterone; D009249:NADP; C014142:19-oxo-delta(4) androstene-3,17-dione; D001141:Aromatase